Advertisement

Site-Directed Therapy for Lung Cancer Metastases

  • Kevin S Oh
  • Baskaran Sundaram
  • Venkataramu Krishnamurthy
  • Allan Pickens
  • Malini Venkatram
  • Ella A Kazerooni
  • Charlie Pan
  • James Hayman
Chapter

Abstract

At the time of diagnosis, 40% of patients with non-small cell lung cancer (NSCLC) and nearly 70% of patients with small cell lung cancer (SCLC) have advanced metastatic disease. The prognosis of patients with advanced lung cancer is dismal, with a 5-year overall survival rate of 1–2%. The primary treatment of advanced disease is supportive care and palliative chemotherapy. However, there is a growing body of evidence suggesting that highly selected patients with oligometastatic disease can achieve long-term survival with ablative forms of site-directed therapy, including surgical resection, external beam radiation therapy (EBRT), stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), and radiofrequency ablation (RFA). This chapter summarizes the experience with site-directed therapy in the management of metastatic lung cancer in the most commonly involved sites: brain, adrenal gland, liver, lung, and bone.

Keywords

Liver Metastasis Brain Metastasis Small Cell Lung Cancer Radiation Therapy Oncology Group Local Control Rate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Naruke T, Tsuchiya R, Kondo H, et al. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. Ann Thorac Surg 2001, 71:1759–1764.PubMedCrossRefGoogle Scholar
  2. 2.
    Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997, 111:1710–1717.PubMedCrossRefGoogle Scholar
  3. 3.
    Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma: analysis of 1000 autopsied cases. Cancer 1950, 3:74–85.PubMedCrossRefGoogle Scholar
  4. 4.
    Engelman RM. Bronchiogenic carcinoma: a statistical review of two hundred and thirty-four autopsies. J Thorac Surg 1954, 27:227–237.PubMedGoogle Scholar
  5. 5.
    Guillan RA, Zelman S, Alonso RA. Adenocarcinoma of the lungs: an analysis of 24 cases in men. Am J Clin Pathol 1967, 47:580–584.PubMedGoogle Scholar
  6. 6.
    Koletsky S. Primary carcinoma of the lung: a clinical and pathologic study of one hundred cases. Arch Int Med 1938, 62:636–651.Google Scholar
  7. 7.
    Onuigbo WI. Some pathological data on 2000 adenocarcinomas and squamous cell carcinomas of the lung. Br J Cancer 1963, 17:1–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Stenbygaard LE, Sørensen JB, Larsen HH, et al. Metastatic pattern in non-resectable non-small cell lung cancer. Acta Oncologica 1999, 38:993–998.PubMedCrossRefGoogle Scholar
  9. 9.
    Stenbygaard LE, Sørensen JB, Olsen JE. Metastatic pattern at autopsy in non-resectable adenocarcinoma of the lung: a study from a cohort of 259 consecutive patients treated with chemotherapy. Acta Oncologica 1997, 36:301–306.PubMedCrossRefGoogle Scholar
  10. 10.
    Strauss B, Weller CV. Bronchogenic carcinoma: a statistical analysis of two hundred ninety-six cases with necropsy as to relationships between cell types and age, sex, and metastasis. Arch Pathol 1957, 63:602–611.Google Scholar
  11. 11.
    Jawahar A, Willis BK, Smith DR, et al. Gamma knife radiosurgery for brain metastases: do patients benefit from adjuvant external-beam radiotherapy? An 18-month comparative analysis. Stereotact Funct Neurosurg 2002, 79: 262–271.PubMedCrossRefGoogle Scholar
  12. 12.
    Varlotto JM, Flickinger JC, Niranjan A, et al. Analysis of tumor control and toxicity in patients who have survived at least one year after radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys 2003, 57:452–464.PubMedCrossRefGoogle Scholar
  13. 13.
    Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997, 37:745–751.PubMedCrossRefGoogle Scholar
  14. 14.
    Nussbaum ES, Djalilian HR, Cho KH, et al. Brain metastases: histology, multiplicity, surgery, and survival. Cancer 1996, 78:1781–1788.PubMedCrossRefGoogle Scholar
  15. 15.
    Borgelt B, Gelber R, Kramer S, et al. The palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1980, 6:1–9.PubMedGoogle Scholar
  16. 16.
    Borgelt B, Gelber R, Larson M, et al. Ultra-rapid high dose irradiation schedules for the palliation of brain metastases: final results of the first two studies by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1981, 7:1633–1638.PubMedCrossRefGoogle Scholar
  17. 17.
    Hankins JR, Miller JE, Salcman M, et al. Surgical management of lung cancer with solitary cerebral metastasis. Ann Thorac Surg 1988, 46:24–28.PubMedCrossRefGoogle Scholar
  18. 18.
    Fuentes R, Bonfill X, Esposito J. Surgery versus radiosurgery for patients with a solitary brain metastasis from non-small cell lung cancer. Cochrane Database Syst Rev 2006, CD004840.Google Scholar
  19. 19.
    Patchell RA, Tibbs PS, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990, 322:494–500.PubMedCrossRefGoogle Scholar
  20. 20.
    Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 1998, 280:1485–1489.PubMedCrossRefGoogle Scholar
  21. 21.
    Shaw E, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 2000, 47:291–298.PubMedCrossRefGoogle Scholar
  22. 22.
    Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004, 363:1665–1672.PubMedCrossRefGoogle Scholar
  23. 23.
    Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 2006, 295:2483–2491.PubMedCrossRefGoogle Scholar
  24. 24.
    Arriagada R, Le Chevalier T, Riviere A, et al. Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients. Ann Oncol 2002, 13:748–754.PubMedCrossRefGoogle Scholar
  25. 25.
    Lester JF, MacBeth FR, Coles B. Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small-cell lung cancer: a Cochrane Review. Int J Radiat Oncol Biol Phys 2005, 63:690–694.PubMedCrossRefGoogle Scholar
  26. 26.
    Auperin A, Arriagada R, Pignon JP, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med 1999, 341:476–484.PubMedCrossRefGoogle Scholar
  27. 27.
    Slotman B, Faivre-Finn C, Kramer G, et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 2007, 357:664–672.PubMedCrossRefGoogle Scholar
  28. 28.
    Ettinghausen SE, Burt ME. Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer. J Clin Oncol 1991, 9:1462–1466.PubMedGoogle Scholar
  29. 29.
    Porte HL, Roumilhac D, Graziana JP, et al. Adrenalectomy for a solitary adrenal metastasis from lung cancer. Ann Thorac Surg 1998, 65:331–335.PubMedCrossRefGoogle Scholar
  30. 30.
    Twomey P, Montgomery C, Clark O. Successful treatment of adrenal metastases from large-cell carcinoma of the lung. JAMA 1982, 248:581–583.PubMedCrossRefGoogle Scholar
  31. 31.
    Luketich JD, Burt ME. Does resection of adrenal metastases from non-small cell lung cancer improve survival? Ann Thorac Surg 1996, 62:1614–1616.PubMedCrossRefGoogle Scholar
  32. 32.
    Luketich JD, Martini N, Ginsberg RJ, et al. Successful treatment of solitary extracranial metastases from non-small cell lung cancer. Ann Thorac Surg 1995, 60:1609–1611.PubMedCrossRefGoogle Scholar
  33. 33.
    de Perrot M, Licker M, Robert JH, et al. Long-term survival after surgical resections of bronchogenic carcinoma and adrenal metastasis. Ann Thorac Surg 1999, 68:1084–1085.PubMedCrossRefGoogle Scholar
  34. 34.
    Raviv G, Klein E, Yellin A, et al. Surgical treatment of solitary adrenal metastases from lung carcinoma. J Surg Oncol 1990, 43:123–124.PubMedCrossRefGoogle Scholar
  35. 35.
    Porte H, Siat J, Guibert B, et al. Resection of adrenal metastases from non-small cell lung cancer: a multicenter study. Ann Thorac Surg 2001, 71:981–985.PubMedCrossRefGoogle Scholar
  36. 36.
    Abdel-Raheem MM, Potti A, Becker WK, et al. Late adrenal metastasis in operable non-small-cell lung carcinoma. Am J Clin Oncol 2002, 25:81–83.PubMedCrossRefGoogle Scholar
  37. 37.
    Heniford BT, Arca MJ, Walsh RM, et al. Laparoscopic adrenalectomy for cancer. Semin Surg Oncol 1999, 16:293–306.PubMedCrossRefGoogle Scholar
  38. 38.
    Baker ME, Pelley R. Hepatic metastases: basic principles and implications for radiologists. Radiology 1995, 197:329–337.PubMedGoogle Scholar
  39. 39.
    Greenlee RT, Murray T, Bolden S, et al. Cancer statistics, 2000. CA Cancer J Clin 2000, 50:7–33.PubMedCrossRefGoogle Scholar
  40. 40.
    Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1999. CA Cancer J Clin 1999, 49:8–31.PubMedCrossRefGoogle Scholar
  41. 41.
    Weiss L, Grundmann E, Torhorst J, et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J Pathol 1986, 150:195–203.PubMedCrossRefGoogle Scholar
  42. 42.
    Kagohashi K, Satoh H, Ishikawa H, et al. Liver metastasis at the time of initial diagnosis of lung cancer. Medical Oncol 2003, 20:25–28.CrossRefGoogle Scholar
  43. 43.
    Fong Y, Cohen AM, Fortner JG, et al. Liver resection for colorectal metastases. J Clin Oncol 1997, 15:938–946.PubMedGoogle Scholar
  44. 44.
    Gayowski TJ, Iwatsuki S, Madariaga JR, et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 1994, 116:703–710.PubMedGoogle Scholar
  45. 45.
    Nordlinger B, Quilichini MA, Parc R, et al. Hepatic resection for colorectal liver metastases. Influence on survival of preoperative factors and surgery for recurrences in 80 patients. Ann Surg 1987, 205:256–263.PubMedCrossRefGoogle Scholar
  46. 46.
    Rosen CB, Nagorney DM, Taswell HF, et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 1992, 216:493–504.PubMedCrossRefGoogle Scholar
  47. 47.
    Singletary SE, Walsh G, Vauthey JN, et al. A role for curative surgery in the treatment of selected patients with metastatic breast cancer. Oncologist 2003, 8:241–251.PubMedCrossRefGoogle Scholar
  48. 48.
    Hao CY, Ji JF. Surgical treatment of liver metastases of colorectal cancer: Strategies and controversies in 2006. Eur J Surg Oncol 2006, 32:473–483.PubMedCrossRefGoogle Scholar
  49. 49.
    Lehnert T, Golling M. Indications and outcome of liver metastases resection. Radiologe 2001, 41:40–48.PubMedCrossRefGoogle Scholar
  50. 50.
    Shumate C. Hepatic resection for colorectal cancer metastases. In: Curley S, ed. Liver Cancer. New York: Springer-Verlag, 1998, 136–149.Google Scholar
  51. 51.
    Siperstein A, Garland A, Engle K, et al. Laparoscopic radiofrequency ablation of primary and metastatic liver tumors: technical considerations. Surg Endoscopy 2000, 14:400–405.CrossRefGoogle Scholar
  52. 52.
    Tuttle T. Hepatectomy for noncolorectal metastases. In: Curley S, ed. Liver Cancer. New York: Springer-Verlag, 1998, 201–211.Google Scholar
  53. 53.
    Di Carlo I., Grasso G, Patane D, et al. Liver metastases from lung cancer: is surgical resection justified? Ann Thorac Surg 2003, 76:291–293.PubMedCrossRefGoogle Scholar
  54. 54.
    Stehlin JS Jr, de Ipolyi PD, Greeff PJ, et al. Treatment of cancer of the liver. Twenty years' experience with infusion and resection in 414 patients. Ann Surg 1988, 208:23–35.PubMedCrossRefGoogle Scholar
  55. 55.
    Berney T, Mentha G, Roth AD, et al. Results of surgical resection of liver metastases from non-colorectal primaries. Br J Surg 1998, 85:1423–1427.PubMedCrossRefGoogle Scholar
  56. 56.
    Cobourn CS, Makowka L, Langer B, et al. Examination of patient selection and outcome for hepatic resection for metastatic disease. Surg Gynecol Obstet 1987, 165:239–246.PubMedGoogle Scholar
  57. 57.
    Foster JH. Survival after liver resection for secondary tumors. Am J Surg 1978, 135:389–394.PubMedCrossRefGoogle Scholar
  58. 58.
    Hamy AP, Paineau JR, Mirallie EC, et al. Hepatic resections for non-colorectal metastases: forty resections in 35 patients. Hepatogastroenterology 2000, 47:1090–1094.PubMedGoogle Scholar
  59. 59.
    Lindell G, Ohlsson B, Saarela A, et al. Liver resection of noncolorectal secondaries. J Surg Oncol 1998, 69:66–70.PubMedCrossRefGoogle Scholar
  60. 60.
    Schwartz SI. Hepatic resection for noncolorectal nonneuroendocrine metastases. World J Surg 1995, 19:72–75.PubMedCrossRefGoogle Scholar
  61. 61.
    Tomas-de la Vega JE, Donahue EJ, Doolas A, et al. A ten year experience with hepatic resection. Surg Gynecol Obstet 1984, 159:223–228.Google Scholar
  62. 62.
    Nagashima A, Abe Y, Yamada S, et al. Long-term survival after surgical resection of liver metastasis from lung cancer. Jpn J Thorac Cardiovasc Surg 2004, 52:311–313.PubMedCrossRefGoogle Scholar
  63. 63.
    Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg 1999, 230:1–8.PubMedCrossRefGoogle Scholar
  64. 64.
    Gillams AR, Lees WR. Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol 2004, 14:2261–2267.PubMedCrossRefGoogle Scholar
  65. 65.
    Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology 2001, 221:159–166.PubMedCrossRefGoogle Scholar
  66. 66.
    Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004, 239:818–825.PubMedCrossRefGoogle Scholar
  67. 67.
    Berber E, Flesher N, Siperstein AE. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases. World J Surg 2002, 26:985–990.PubMedCrossRefGoogle Scholar
  68. 68.
    Gillams A, Cassoni A, Conway G, et al. Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience. Abdom Imaging 2005, 30:435–441.PubMedCrossRefGoogle Scholar
  69. 69.
    Jakobs TF, Hoffmann RT, Trumm C, et al. Radiofrequency ablation of colorectal liver metastases: mid-term results in 68 patients. Anticancer Res 2006, 26:671–680.PubMedGoogle Scholar
  70. 70.
    Lencioni R, Crocetti L, Cioni D, et al. Percutaneous radiofrequency ablation of hepatic colorectal metastases: technique, indications, results, and new promises. Invest Radiol 2004, 39:689–697.PubMedCrossRefGoogle Scholar
  71. 71.
    Pawlik TM, Izzo F, Cohen DS, et al. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol 2003, 10:1059–1069.PubMedCrossRefGoogle Scholar
  72. 72.
    Siperstein AE, Berber E. Cryoablation, percutaneous alcohol injection, and radiofrequency ablation for treatment of neuroendocrine liver metastases. World J Surg 2001, 25:693–696.PubMedCrossRefGoogle Scholar
  73. 73.
    Abraham J, Fojo T, Wood BJ. Radiofrequency ablation of metastatic lesions in adrenocortical cancer. Ann Intern Med 2000, 133:312–313.PubMedGoogle Scholar
  74. 74.
    Livraghi T, Goldberg SN, Solbiati L, et al. Percutaneous radio-frequency ablation of liver metastases from breast cancer: initial experience in 24 patients. Radiology 2001, 220:145–149.PubMedGoogle Scholar
  75. 75.
    Curley SA. Radiofrequency ablation of malignant liver tumors. Oncologist 2001, 6:14–23.PubMedCrossRefGoogle Scholar
  76. 76.
    Dickson JA, Calderwood SK. Temperature range and selective sensitivity of tumors to hyperthermia: a critical review. Ann N Y Acad Sci 1980, 335:180–205.PubMedCrossRefGoogle Scholar
  77. 77.
    Goldberg SN. Radiofrequency tumor ablation: principles and techniques. Eur J Ultrasound 2001, 13:129–147.PubMedCrossRefGoogle Scholar
  78. 78.
    Aschoff AJ, Merkle EM, Wong V, et al. How does alteration of hepatic blood flow affect liver perfusion and radiofrequency-induced thermal lesion size in rabbit liver? J Magn Reson Imaging 2001, 13:57–63.PubMedCrossRefGoogle Scholar
  79. 79.
    Chinn SB, Lee FT Jr, Kennedy GD, et al. Effect of vascular occlusion on radiofrequency ablation of the liver: results in a porcine model. AJR Am J Roentgenol 2001, 176:789–795.PubMedGoogle Scholar
  80. 80.
    Curley SA, Izzo F, Ellis LM, et al. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg 2000, 232:381–391.PubMedCrossRefGoogle Scholar
  81. 81.
    Patterson EJ, Scudamore CH, Owen DA, et al. Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. Ann Surg 1998, 227:559–565.PubMedCrossRefGoogle Scholar
  82. 82.
    Rossi S, Garbagnati F, De Francesco I, et al. Relationship between the shape and size of radiofrequency induced thermal lesions and hepatic vascularization. Tumori 1999, 85:128–132.PubMedGoogle Scholar
  83. 83.
    Aloia TA, Vauthey JN, Loyer EM, et al. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg 2006, 141:460–466.PubMedCrossRefGoogle Scholar
  84. 84.
    Amersi FF, McElrath-Garza A, Ahmad A, et al. Long-term survival after radiofrequency ablation of complex unresectable liver tumors. Arch Surg 2006, 141:581–587.PubMedCrossRefGoogle Scholar
  85. 85.
    Berber E, Pelley R, Siperstein AE. Predictors of survival after radiofrequency thermal ablation of colorectal cancer metastases to the liver: a prospective study. J Clin Oncol 2005, 23:1358–1364.PubMedCrossRefGoogle Scholar
  86. 86.
    van Duijnhoven FH, Jansen MC, Junggeburt JM, et al. Factors influencing the local failure rate of radiofrequency ablation of colorectal liver metastases. Ann Surg Oncol 2006, 13:651–658.PubMedCrossRefGoogle Scholar
  87. 87.
    de Baere T, Elias D, Dromain C, et al. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol 2000, 175:1619–1625.PubMedGoogle Scholar
  88. 88.
    Wood TF, Rose DM, Chung M, et al. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications. Ann Surg Oncol 2000, 7:593–600.PubMedGoogle Scholar
  89. 89.
    Buscarini E, Savoia A, Brambilla G, Radiofrequency thermal ablation of liver tumors. Eur Radiol 2005, 15:884–894.PubMedCrossRefGoogle Scholar
  90. 90.
    Goldberg SN, Charboneau JW, Dodd GD 3rd, et al. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 2003, 228:335–345.PubMedCrossRefGoogle Scholar
  91. 91.
    Timmerman RD, Kavanagh BD, Cho LC, et al. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol 2007, 25:947–952.PubMedCrossRefGoogle Scholar
  92. 92.
    Fowler JF. The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 1989, 62:679–694.PubMedCrossRefGoogle Scholar
  93. 93.
    Blomgren H, Lax I, Naslund I, et al. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 1995, 34:861–870.PubMedCrossRefGoogle Scholar
  94. 94.
    Herfarth KK, Debus J, Lohr F, et al. Stereotactic single-dose radiation therapy of liver tumors: results of a phase I/II trial. J Clin Oncol 2001, 19:164–170.PubMedGoogle Scholar
  95. 95.
    Wulf J, Hadinger U, Oppitz U, et al. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 2001, 177:645–655.PubMedCrossRefGoogle Scholar
  96. 96.
    Wulf J, Guckenberger M, Haedinger U, et al. Stereotactic radiotherapy of primary liver cancer and hepatic metastases. Acta Oncol 2006, 45:838–847.PubMedCrossRefGoogle Scholar
  97. 97.
    Schefter TE, Kavanagh BD, Timmerman RD, et al. A phase I trial of stereotactic body radiation therapy for liver metastases. Int J Radiat Oncol Biol Phys 2005, 62:1371–1378.PubMedCrossRefGoogle Scholar
  98. 98.
    Kavanagh BD, Schefter TE, Cardenes HR, et al. Interim analysis of a prospective phase I/II trial of SBRT for liver metastases. Acta Oncol 2006, 45:848–855.PubMedCrossRefGoogle Scholar
  99. 99.
    Divis G. Einbertrag zur operativen, Behandlung der Lungengeschuuilste. Acta Chir Scand 1927, 62:329.Google Scholar
  100. 100.
    Kondo H, Okumura T, Ohde Y, et al. Surgical treatment for metastatic malignancies. Pulmonary metastasis: indications and outcomes. Int J Clin Oncol 2005, 10:81–85.PubMedCrossRefGoogle Scholar
  101. 101.
    Pfannschmidt J, Klode J, Muley T, et al. Nodal involvement at the time of pulmonary metastasectomy: experiences in 245 patients. Ann Thorac Surg 2006, 81:448–454.PubMedCrossRefGoogle Scholar
  102. 102.
    Pastorino U, Buyse M, Friedel G, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The International Registry of Lung Metastases. J Thorac Cardiovasc Surg 1997, 113:37–49.CrossRefGoogle Scholar
  103. 103.
    Robert JH, Ambrogi V, Mermillod B, et al. Factors influencing long-term survival after lung metastasectomy. Ann Thorac Surg 1997, 63:777–784.PubMedCrossRefGoogle Scholar
  104. 104.
    Mason RJ, Nadel JA, eds. Textbook of Respiratory Medicine. 4th edition. Philadelphia: Elsevier Saunders, 2005.Google Scholar
  105. 105.
    Thomford NR, Woolner LB, Clagett OT. The surgical treatment of metastatic tumors in the lungs. J Thorac Cardiovasc Surg 1965, 49:357–363.PubMedGoogle Scholar
  106. 106.
    Ketchedjian A, Daly B, Luketich J, et al. Minimally invasive techniques for managing pulmonary metastases: video-assisted thoracic surgery and radiofrequency ablation. Thorac Surg Clin 2006, 16:157–165.PubMedCrossRefGoogle Scholar
  107. 107.
    Pastorino U, Buyse M, Friedel G, et al. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. AATS/WTSA, 1997.Google Scholar
  108. 108.
    McCormack PM, Attiyeh FF. Resected pulmonary metastases from colorectal cancer. Dis Colon Rectum 1979, 22:553–556.PubMedCrossRefGoogle Scholar
  109. 109.
    Okumura S, Kondo H, Tsuboi M, et al. Pulmonary resection for metastatic colorectal cancer: experiences with 159 patients. J Thorac Cardiovasc Surg 1996, 112:867–874.PubMedCrossRefGoogle Scholar
  110. 110.
    Saito Y, Omiya H, Kohno K, et al. Pulmonary metastasectomy for 165 patients with colorectal carcinoma: A prognostic assessment. J Thorac Cardiovasc Surg 2002, 124:1007–1013.PubMedCrossRefGoogle Scholar
  111. 111.
    Cerfolio RJ, Allen MS, Deschamps C, et al. Pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg 1994, 57:339–344.PubMedCrossRefGoogle Scholar
  112. 112.
    Piltz S, Meimarakis G, Wichmann MW, et al. Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann Thorac Surg 2002, 73:1082–1087.PubMedCrossRefGoogle Scholar
  113. 113.
    Anraku M, Yokoi K, Nakagawa K, et al. Pulmonary metastases from uterine malignancies: results of surgical resection in 133 patients. J Thorac Cardiovasc Surg 2004, 127:1107–1112.PubMedCrossRefGoogle Scholar
  114. 114.
    Liu D, Labow DM, Dang N, et al. Pulmonary metastasectomy for head and neck cancers. Ann Surg Oncol 1999, 6:572–578.PubMedCrossRefGoogle Scholar
  115. 115.
    Fukuse T, Hirata T, Tanaka F, et al. Prognosis of ipsilateral intrapulmonary metastases in resected nonsmall cell lung cancer. Eur J Cardiothorac Surg 1997, 12:218–223.PubMedCrossRefGoogle Scholar
  116. 116.
    Okada M, Tsubota N, Yoshimura M, et al. Evaluation of TMN classification for lung carcinoma with ipsilateral intrapulmonary metastasis. Ann Thorac Surg 1999, 68:326–330.PubMedCrossRefGoogle Scholar
  117. 117.
    Nagai K, Sohara Y, Tsuchiya R, et al. Prognosis of resected non-small cell lung cancer patients with intrapulmonary metastases. J Thorac Oncol 2007, 2:282–286.PubMedCrossRefGoogle Scholar
  118. 118.
    Ahrar K, Price RE, Wallace MJ, et al. Percutaneous radiofrequency ablation of lung tumors in a large animal model. J Vasc Interv Radiol 2003, 14:1037–1043.PubMedGoogle Scholar
  119. 119.
    Ahmed M, Liu Z, Afzal KS, et al. Radiofrequency ablation: effect of surrounding tissue composition on coagulation necrosis in a canine tumor model. Radiology 2004, 230:761–767.PubMedCrossRefGoogle Scholar
  120. 120.
    Miao Y, Ni Y, Bosmans H, et al. Radiofrequency ablation for eradication of pulmonary tumor in rabbits. J Surg Res 2001, 99:265–271.PubMedCrossRefGoogle Scholar
  121. 121.
    Goldberg SN, Gazelle GS, Compton CC, et al. Radiofrequency tissue ablation in the rabbit lung: efficacy and complications. Acad Radiol 1995, 2:776–784.PubMedCrossRefGoogle Scholar
  122. 122.
    Yasui K, Kanazawa S, Sano Y, et al. Thoracic tumors treated with CT-guided radiofrequency ablation: initial experience. Radiology 2004, 231:850–857.PubMedCrossRefGoogle Scholar
  123. 123.
    Yan TD, King J, Ebrahimi A, et al. Hepatectomy and lung radiofrequency ablation for hepatic and subsequent pulmonary metastases from colorectal carcinoma. J Surg Oncol 2007, 96:367–373.PubMedCrossRefGoogle Scholar
  124. 124.
    Yan TD, King J, Sjarif A, et al. Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival. Ann Surg Oncol 2006, 13:1529–1537.PubMedCrossRefGoogle Scholar
  125. 125.
    Yan TD, King J, Sjarif A, et al. Treatment failure after percutaneous radiofrequency ablation for nonsurgical candidates with pulmonary metastases from colorectal carcinoma. Ann Surg Oncol 2007, 14:1718–1726.PubMedCrossRefGoogle Scholar
  126. 126.
    Yamakado K, Hase S, Matsuoka T, et al. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan. J Vasc Interv Radiol 2007, 18:393–398.PubMedCrossRefGoogle Scholar
  127. 127.
    Vogl TJ, Straub R, Lehnert T, et al. Percutaneous thermoablation of pulmonary metastases. Experience with the application of laser-induced thermotherapy and radiofrequency ablation, and a literature review. Rofo 2004, 176:1658–1666.PubMedGoogle Scholar
  128. 128.
    Steinke K, Glenn D, King J, et al. Percutaneous imaging-guided radiofrequency ablation in patients with colorectal pulmonary metastases: 1-year follow-up. Ann Surg Oncol 2004, 11:207–212.PubMedCrossRefGoogle Scholar
  129. 129.
    King J, Glenn D, Clark W, et al. Percutaneous radiofrequency ablation of pulmonary metastases in patients with colorectal cancer. Br J Surg 2004, 91:217–223.PubMedCrossRefGoogle Scholar
  130. 130.
    Simon CJ, Dupuy DE, DiPetrillo TA, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 2007, 243:268–275.PubMedCrossRefGoogle Scholar
  131. 131.
    Lagana D, Carrafiello G, Mangini M, et al. Radiofrequency ablation of primary and metastatic lung tumors: preliminary experience with a single center device. Surg Endosc 2006, 20:1262–1267.PubMedCrossRefGoogle Scholar
  132. 132.
    Kishi K, Nakamura H, Kobayashi K, et al. Percutaneous CT-guided radiofrequency ablation of pulmonary malignant tumors: preliminary report. Intern Med 2006, 45:65–72.PubMedCrossRefGoogle Scholar
  133. 133.
    Rossi S, Dore R, Cascina A, et al. Percutaneous computed tomography-guided radiofrequency thermal ablation of small unresectable lung tumours. Eur Respir J 2006, 27:556–563.PubMedCrossRefGoogle Scholar
  134. 134.
    Thanos L, Mylona S, Pomoni M, et al. Percutaneous radiofrequency thermal ablation of primary and metastatic lung tumors. Eur J Cardiothorac Surg 2006, 30:797–800.PubMedCrossRefGoogle Scholar
  135. 135.
    Ambrogi MC, Lucchi M, Dini P, et al. Percutaneous radiofrequency ablation of lung tumours: results in the mid-term. Eur J Cardiothorac Surg 2006, 30:177–183.PubMedCrossRefGoogle Scholar
  136. 136.
    Akeboshi M, Yamakado K, Nakatsuka A, Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. J Vasc Interv Radiol 2004, 15:463–470.PubMedGoogle Scholar
  137. 137.
    Lee JM, Jin GY, Goldberg SN, et al. Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology 2004, 230:125–134.PubMedCrossRefGoogle Scholar
  138. 138.
    Hiraki T, Sakurai J, Tsuda T, et al. Risk factors for local progression after percutaneous radiofrequency ablation of lung tumors: evaluation based on a preliminary review of 342 tumors. Cancer 2006, 107:2873–2880.PubMedCrossRefGoogle Scholar
  139. 139.
    Nguyen CL, Scott WJ, Young NA, et al. Radiofrequency ablation of primary lung cancer: results from an ablate and resect pilot study. Chest 2005, 128:3507–3511.PubMedCrossRefGoogle Scholar
  140. 140.
    Nomori H, Imazu Y, Watanabe K, et al. Radiofrequency ablation of pulmonary tumors and normal lung tissue in swine and rabbits. Chest 2005, 127:973–977.PubMedCrossRefGoogle Scholar
  141. 141.
    Iguchi T, Hiraki T, Gobara H, et al. Percutaneous radiofrequency ablation of lung tumors close to the heart or aorta: evaluation of safety and effectiveness. J Vasc Interv Radiol 2007, 18:733–740.PubMedCrossRefGoogle Scholar
  142. 142.
    Steinke K, Haghighi KS, Wulf S, et al. Effect of vessel diameter on the creation of ovine lung radiofrequency lesions in vivo: preliminary results. J Surg Res 2005, 124:85–91.PubMedCrossRefGoogle Scholar
  143. 143.
    Yamamoto A, Nakamura K, Matsuoka T, et al. Radiofrequency ablation in a porcine lung model: correlation between CT and histopathologic findings. AJR Am J Roentgenol 2005, 185:1299–1306.PubMedCrossRefGoogle Scholar
  144. 144.
    Tominaga J, Miyachi H, Takase K, et al. Time-related changes in computed tomographic appearance and pathologic findings after radiofrequency ablation of the rabbit lung: preliminary experimental study. J Vasc Interv Radiol 2005, 16:1719–1726.PubMedGoogle Scholar
  145. 145.
    Bojarski JD, Dupuy DE, Mayo-Smith WW. CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors. AJR Am J Roentgenol 2005, 185:466–471.PubMedGoogle Scholar
  146. 146.
    Gillams AR, Lees WR. Analysis of the factors associated with radiofrequency ablation-induced pneumothorax. Clin Radiol 2007, 62:639–644.PubMedCrossRefGoogle Scholar
  147. 147.
    Hiraki T, Tajiri N, Mimura H, et al. Pneumothorax, pleural effusion, and chest tube placement after radiofrequency ablation of lung tumors: incidence and risk factors. Radiology 2006, 241:275–283.PubMedCrossRefGoogle Scholar
  148. 148.
    Yamagami T, Kato T, Hirota T, et al. Pneumothorax as a complication of percutaneous radiofrequency ablation for lung neoplasms. J Vasc Interv Radiol 2006, 17:1625–1629.PubMedCrossRefGoogle Scholar
  149. 149.
    Sano Y, Kanazawa S, Gobara H, et al. Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies: a large single-center experience. Cancer 2007, 109:1397–1405.PubMedCrossRefGoogle Scholar
  150. 150.
    Ng K, Yan TD, Zhu JC, et al. Percutaneous radiofrequency ablation of lung tumours: prognostic risk factors for local progression. ANZ J Surg 2007, 77:A89.CrossRefGoogle Scholar
  151. 151.
    Timmerman R, Papiez L, McGarry R, et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003, 124:1946–1955.PubMedCrossRefGoogle Scholar
  152. 152.
    McGarry RC, Papiez L, Williams M, et al. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 2005, 63:1010–1015.PubMedCrossRefGoogle Scholar
  153. 153.
    Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 2006, 24:4833–4839.PubMedCrossRefGoogle Scholar
  154. 154.
    Baumann P, Nyman J, Lax I, et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol 2006 45:787–795.PubMedCrossRefGoogle Scholar
  155. 155.
    Fritz P, Kraus HJ, Muhlnickel W, et al. Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases. Radiat Oncol 2006, 1:30.PubMedCrossRefGoogle Scholar
  156. 156.
    Hara R, Itami J, Kondo T, et al. Clinical outcomes of single-fraction stereotactic radiation therapy of lung tumors. Cancer 2006, 106:1347–1352.PubMedCrossRefGoogle Scholar
  157. 157.
    Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005, 63:1427–1431.PubMedCrossRefGoogle Scholar
  158. 158.
    Nyman J, Johansson KA, Hulten U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer–mature results for medically inoperable patients. Lung Cancer 2006, 51:97–103.PubMedCrossRefGoogle Scholar
  159. 159.
    Xia T, Li H, Sun Q, et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006, 66:117–125.PubMedCrossRefGoogle Scholar
  160. 160.
    Zimmermann FB, Geinitz H, Schill S, et al. Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer. Lung Cancer 2005, 48:107–114.PubMedCrossRefGoogle Scholar
  161. 161.
    Nagata Y, Negoro Y, Aoki T, et al. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2002, 52:1041–1046.PubMedCrossRefGoogle Scholar
  162. 162.
    Okunieff P, Petersen AL, Philip A, et al. Stereotactic body radiation therapy for lung metastases. Acta Oncol 2006, 45:808–817.PubMedCrossRefGoogle Scholar
  163. 163.
    Yoon SM, Choi EK, Lee SW, et al. Clinical results of stereotactic body frame based fractionated radiation therapy for primary or metastatic thoracic tumors. Acta Oncologica 2006, 45:1108–1114.PubMedCrossRefGoogle Scholar
  164. 164.
    Nakagawa K, Aoki Y, Tago M, et al. Megavoltage CT-assisted stereotactic radiosurgery for thoracic tumors: original research in the treatment of thoracic neoplasms. Int J Radiat Oncol Biol Phys 2000, 48:449–457.PubMedCrossRefGoogle Scholar
  165. 165.
    Jeremic B, Shibamoto Y, Nikolic N, et al. Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: A randomized study. J Clin Oncol 1999, 17:2092–2099.PubMedGoogle Scholar
  166. 166.
    Brincker H, Hindberg J, Hansen PV. Cyclic alternating polychemotherapy with or without upper and lower half-body irradiation in small cell anaplastic lung cancer. A randomized study. Eur J Cancer Clin Oncol 1987, 23:205–211.PubMedCrossRefGoogle Scholar
  167. 167.
    Lebeau B, Chastang C, Brechot JM, et al. A randomized trial of delayed thoracic radiotherapy in complete responder patients with small-cell lung cancer. Chest 1993, 104:726–733.PubMedCrossRefGoogle Scholar
  168. 168.
    Nou E, Brodin O, Bergh J. A randomized study of radiation treatment in small cell bronchial carcinoma treated with two types of four-drug chemotherapy regimens. Cancer 1988, 62:1079–1090.PubMedCrossRefGoogle Scholar
  169. 169.
    Stanley KE. Prognostic factors for survival in patients with inoperable lung cancer. J Natl Cancer Inst 1980, 65:25–32.PubMedGoogle Scholar
  170. 170.
    Hirano Y, Oda M, Tsunezuka Y, et al. Long-term survival cases of lung cancer presented as solitary bone metastasis. Ann Thorac Cardiovasc Surg 2005, 11:401–404.PubMedGoogle Scholar
  171. 171.
    Tong D, Gillick L, Hendrickson FR. The palliation of symptomatic osseous metastases: final results of the study by the Radiation Therapy Oncology Group. Cancer 1982, 50:893–899.PubMedCrossRefGoogle Scholar
  172. 172.
    Blitzer PH. Reanalysis of the RTOG study of the palliation of symptomatic osseous metastasis. Cancer 1985, 55:1468–1472.PubMedCrossRefGoogle Scholar
  173. 173.
    Steenland E, Leer JW, van Houwelingen H, et al. The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 1999, 52:101–109.PubMedCrossRefGoogle Scholar
  174. 174.
    van der Linden YM, Steenland E, van Houwelingen HC, et al. Patients with a favourable prognosis are equally palliated with single and multiple fraction radiotherapy: results on survival in the Dutch Bone Metastasis Study. Radiother Oncol 2006, 78:245–253.PubMedCrossRefGoogle Scholar
  175. 175.
    Hartsell WF, Scott CB, Bruner DW, et al. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst 2005, 97:798–804.PubMedCrossRefGoogle Scholar
  176. 176.
    Bone Pain Trial Working Party. 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Radiother Oncol 1999, 52:111–121.CrossRefGoogle Scholar
  177. 177.
    Roos DE, Turner SL, O‘Brien PC, et al. Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiother Oncol 2005, 75:54–63.PubMedCrossRefGoogle Scholar
  178. 178.
    Kaasa S, Brenne E, Lund JA, et al. Prospective randomised multicenter trial on single fraction radiotherapy (8 Gy x 1) versus multiple fractions (3 Gy x 10) in the treatment of painful bone metastases. Radiother Oncol 2006, 79:278–284.PubMedCrossRefGoogle Scholar
  179. 179.
    Patchell RA, Tibbs PA, Regine WF, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 2005, 366:643–648.PubMedCrossRefGoogle Scholar
  180. 180.
    Hamilton AJ, Lulu BA, Fosmire H, et al. Preliminary clinical experience with linear accelerator-based spinal stereotactic radiosurgery. Neurosurg 1995, 36:311–319.CrossRefGoogle Scholar
  181. 181.
    Benzil DL, Saboori M, Mogilner AY, et al. Safety and efficacy of stereotactic radiosurgery for tumors of the spine. J Neurosurg 2004, 101: 413–418.PubMedGoogle Scholar
  182. 182.
    Bilsky MH, Yamada Y, Yenice KM, et al. Intensity-modulated stereotactic radiotherapy of paraspinal tumors: a preliminary report. Neurosurg 2004, 54:823–830.CrossRefGoogle Scholar
  183. 183.
    De Salles AA, Pedroso AG, Medin P, et al. Spinal lesions treated with Novalis shaped beam intensity-modulated radiosurgery and stereotactic radiotherapy. J Neurosurg 2004, 101:435–440.PubMedCrossRefGoogle Scholar
  184. 184.
    Gerszten PC, Welch WC. Cyberknife radiosurgery for metastatic spine tumors. Neurosurg Clin N Am 2004, 15:491–501.PubMedCrossRefGoogle Scholar
  185. 185.
    Medin PM, Solberg TD, De Salles AA, et al. Investigations of a minimally invasive method for treatment of spinal malignancies with LINAC stereotactic radiation therapy: accuracy and animal studies. Int J Radiat Oncol Biol Phys 2002, 52:1111–1122.PubMedCrossRefGoogle Scholar
  186. 186.
    Milker-Zabel S, Zabel A, Thilmann C, et al. Clinical results of retreatment of vertebral bone metastases by stereotactic conformal radiotherapy and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2003, 55:162–167.PubMedCrossRefGoogle Scholar
  187. 187.
    Ryu S, Yin FF, Rock J, et al. Image-guided and intensity-modulated radiosurgery for patients with spinal metastasis. Cancer 2003, 97:2013–2018.PubMedCrossRefGoogle Scholar
  188. 188.
    Ryu S, Rock J, Rosenblum M, et al. Patterns of failure after single-dose radiosurgery for spinal metastasis. J Neurosurg 2004, 101:402–405.PubMedCrossRefGoogle Scholar
  189. 189.
    Ryu SI, Chang SD, Kim DH, et al. Image-guided hypo-fractionated stereotactic radiosurgery to spinal lesions. Neurosurg 2001, 49:838–846.CrossRefGoogle Scholar
  190. 190.
    Yin FF, Ryu S, Ajlouni M, et al. Image-guided procedures for intensity-modulated spinal radiosurgery. Technical note. J Neurosurg 2004, 101:419–424.PubMedGoogle Scholar
  191. 191.
    Chang EL, Shiu AS, Mendel E, et al. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. Spine 2007, 7:151–160.PubMedGoogle Scholar
  192. 192.
    Mussi A, Janni A, Pistolesi M, et al. Surgical treatment of primary lung cancer and solitary brain metastasis. Thorax 1985, 40:191–193.PubMedCrossRefGoogle Scholar
  193. 193.
    Magilligan DJ Jr, Duvernoy C, Malik G, et al. Surgical approach to lung cancer with solitary cerebral metastasis: twenty-five years' experience. Ann Thorac Surg 1986, 42:360–364.PubMedCrossRefGoogle Scholar
  194. 194.
    Rossi NP, Zavala DC, VanGilder JC. A combined surgical approach to non-oat-cell pulmonary carcinoma with single cerebral metastasis. Respiration 1987, 51:170–178.PubMedCrossRefGoogle Scholar
  195. 195.
    Torre M, Quaini E, Chiesa G, et al. Synchronous brain metastasis from lung cancer. Result of surgical treatment in combined resection. J Thorac Cardiovasc Surg 1988, 95:994–997.PubMedGoogle Scholar
  196. 196.
    Macchiarini P, Buonaguidi R, Hardin M, et al. Results and prognostic factors of surgery in the management of non-small cell lung cancer with solitary brain metastasis. Cancer 1991, 68:300–304.PubMedCrossRefGoogle Scholar
  197. 197.
    Burt M, Wronski M, Arbit E, et al. Resection of brain metastases from non-small-cell lung carcinoma. Results of therapy. Memorial Sloan-Kettering Cancer Center thoracic surgical staff. J Thorac Cardiovasc Surg 1992, 103:399–410.PubMedGoogle Scholar
  198. 198.
    Wronski M, Arbit E, Burt M, et al. Survival after surgical treatment of brain metastases from lung cancer: a follow-up study of 231 patients treated between 1976 and 1991. J Neurosurg 1995, 83:605–616.PubMedCrossRefGoogle Scholar
  199. 199.
    Saitoh Y, Fujisawa T, Shiba M, et al. Prognostic factors in surgical treatment of solitary brain metastasis after resection of non-small-cell lung cancer. Lung Cancer 1999, 24:99–106.PubMedCrossRefGoogle Scholar
  200. 200.
    Billing PS, Miller DL, Allen MS, et al. Surgical treatment of primary lung cancer with synchronous brain metastases. J Thorac Cardiovasc Surg 2001, 122:548–553.PubMedCrossRefGoogle Scholar
  201. 201.
    Bonnette P, Puyo P, Gabriel C, et al. Surgical management of non-small cell lung cancer with synchronous brain metastases. Chest 2001, 119:1469–1475.PubMedCrossRefGoogle Scholar
  202. 202.
    Herrera LJ, Fernando HC, Perry Y, et al. Radiofrequency ablation of pulmonary malignant tumors in nonsurgical candidates. J Thorac Cardiovasc Surg 2003, 125:929–937.PubMedCrossRefGoogle Scholar
  203. 203.
    Kang S, Luo R, Liao W, et al. Single group study to evaluate the feasibility and complications of radiofrequency ablation and usefulness of post treatment position emission tomography in lung tumours. World J Surg Oncol 2004, 2:30.PubMedCrossRefGoogle Scholar
  204. 204.
    VanSonnenberg E, Shankar S, Morrison PR, et al. Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience: technical and multidisciplinary considerations in 30 patients. AJR Am J Roentgenol 2005, 184:381–390.PubMedGoogle Scholar
  205. 205.
    Gadaleta C, Catino A, Mattioli V. Radiofrequency thermal ablation in the treatment of lung malignancies. In Vivo 2006, 20:765–767.PubMedGoogle Scholar
  206. 206.
    Hoffmann RT, Jakobs TF, Lubienski A, et al. Percutaneous radiofrequency ablation of pulmonary tumors: Is there a difference between treatment under general anaesthesia and under conscious sedation? Eur J Radiol 2006, 59:168–174.PubMedCrossRefGoogle Scholar
  207. 207.
    de Baere T, Palussiere J, Auperin A, et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology 2006, 240:587–596.PubMedCrossRefGoogle Scholar
  208. 208.
    Blomgren H, Lax I, Göranson H, et al. Radiosurgery for tumors in the body: clinical experience using a new method. J Radiosurg 1998, 1:63–74.CrossRefGoogle Scholar
  209. 209.
    Uematsu M, Shioda A, Tahara K, et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer 1998, 82:1062–1070.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Kevin S Oh
    • 1
  • Baskaran Sundaram
    • 2
  • Venkataramu Krishnamurthy
    • 2
  • Allan Pickens
    • 3
  • Malini Venkatram
    • 4
  • Ella A Kazerooni
    • 2
  • Charlie Pan
    • 5
  • James Hayman
    • 5
  1. 1.Department of Radiation OncologyMassachusetts General HospitalBostonUSA
  2. 2.Department of RadiologyUniversity of MichiganAnn ArborUSA
  3. 3.Section of Thoracic Surgery, Department of SurgeryUniversity of MichiganAnn ArborUSA
  4. 4.Department of Internal MedicineSinai-Grace/Wayne State UniversityDetroitUSA
  5. 5.Department of Radiation OncologyUniversity of MichiganAnn ArborUSA

Personalised recommendations